$LABT
Lakewood-Amedex Biotherapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · University Park, FL
LABT chart
What traders are saying about $LABT
Latest postsLakewood-Amedex Biotherapeutics Inc. news
- Lakewood-Amedex Biotherapeutics Inc. Estimates – NASDAQ:LABT
TradingView ·
- Lakewood-Amedex presents Nu-3 antimicrobial data at IDWeek 2026
StreetInsider ·
- Lakewood-Amedex Biotherapeutics Presents Data Highlighting Nu-3's Broad-Spectrum Antimicrobial Activity and Low Potential for Resistance at IDWeek 2026
Yahoo Finance ·
- A drug candidate killed resistant bacteria in minutes in lab tests. It’s in a foot-ulcer trial.
Stock Titan ·
- Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds
Yahoo Finance ·
- Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences
Yahoo Finance ·
- Lakewood-Amedex doses first patient in Phase 2a trial for Diabetic foot infections
Yahoo Finance ·
- Lakewood-Amedex Reports Positive Nu-3 MIC Data Against Diabetic Foot Ulcer Clinical Isolates
investorshub.advfn.com ·
- LABT: First Patient Dosed in Phase 2a Trial of Nu-3 for Infected Diabetic Foot Ulcers
Yahoo Finance ·
- Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers
Yahoo Finance ·
- Beyond Antibiotics: Lakewood-Amedex Advances Diabetic Foot Ulcer Trial
Yahoo Finance ·
- Lakewood-Amedex Biotherapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of Nu-3 for Infected Diabetic Foot Ulcers
Yahoo Finance ·
Lakewood-Amedex Biotherapeutics Inc. key financials
| USD | 2025 | 2024 |
|---|---|---|
| Net income | -$3.8M | -$4.9M |
| Diluted EPS | $-8.40 | $-9.92 |
| Total assets (year end) | $481,598 | $1.1M |
| Cash and equivalents (year end) | $236,400 | $681,098 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lakewood-Amedex Biotherapeutics Inc.
- Ticker
- LABT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- University Park, FL
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 2079272
Frequently asked questions
What exchange is Lakewood-Amedex Biotherapeutics Inc. listed on?
Lakewood-Amedex Biotherapeutics Inc. trades on the Nasdaq under the ticker symbol LABT.
What industry is Lakewood-Amedex Biotherapeutics Inc. in?
Lakewood-Amedex Biotherapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Lakewood-Amedex Biotherapeutics Inc. headquartered?
Lakewood-Amedex Biotherapeutics Inc.'s business address on file with the SEC is in University Park, FL.
When does Lakewood-Amedex Biotherapeutics Inc.'s fiscal year end?
Lakewood-Amedex Biotherapeutics Inc.'s fiscal year ends on December 31.